The FDA is altering its COVID-19 vaccination policy, emphasizing more stringent approval processes for vaccines aimed at lower-risk populations. This change prioritizes individuals over 65 and those with risk factors, while creating barriers for general access to booster vaccines for healthier populations. Critics, including health experts, argue that these restrictions could limit vaccine access and undermine overall vaccination efforts. Notably, these policy shifts follow staffing changes in the Department of Health and Human Services, linked to public health figures opposed to broad vaccine access.
The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk.
This is overly restrictive and will deny many people who want to be vaccinated a vaccine, says Anna Durbin.
This will make vaccines less insurable and less available, warns Paul Offit.
Collection
[
|
...
]